Initial phase III trial results from November 2020 suggested that, after two doses, new mRNA vaccines developed by Moderna ...
The Trump administration’s official policy during both of his terms has been to use the president's hand signature on every ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results